Back to Search
Start Over
Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
- Source :
- Neurology and Therapy
- Publication Year :
- 2021
- Publisher :
- Springer Science and Business Media LLC, 2021.
-
Abstract
- Graphical Plain Language Summary COVID-19 vaccines are safe for people living with MS on or off disease-modifying therapies and are important for the prevention of COVID-19. Antibody responses for individuals on certain DMTs may be diminished, however, T-cell responses may be preserved in those individuals. Data are lacking regarding optimal timing of vaccinations, and delaying disease-modifying therapies may increase the risk of disease activity and progression. In this perspective podcast, the authors recommend COVID-19 vaccination as soon as possible, regardless of timing considerations, in most cases. Electronic supplementary material The online version of this article (10.1007/s40120-021-00266-z) contains supplementary material, which is available to authorized users.
- Subjects :
- Vaccines
medicine.medical_specialty
2019-20 coronavirus outbreak
Disease modifying therapy
Coronavirus disease 2019 (COVID-19)
SARS-CoV-2
business.industry
Multiple sclerosis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
COVID-19
Patient education
medicine.disease
Coronavirus
Vaccination
Disease activity
Antibody response
Neurology
Commentary
medicine
Neurology (clinical)
B-cell-targeting therapy
business
Intensive care medicine
Subjects
Details
- ISSN :
- 21936536 and 21938253
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- Neurology and Therapy
- Accession number :
- edsair.doi.dedup.....8043de885b6b3c449e4a770ec83dc101
- Full Text :
- https://doi.org/10.1007/s40120-021-00266-z